Suzhou Fengbei Biotech Stock Co (SHSE:603334) Marketable Securities: ¥330 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603334 Suzhou Fengbei Biotech Stock Co Ltd SHSE:603334
44 GF Score
Price ¥29.84
! 4 Warning Signs
View Full Analysis

What is Suzhou Fengbei Biotech Stock Co Marketable Securities?

Suzhou Fengbei Biotech Stock Co SHSE:603334 -2.67% 44 Marketable Securities is ¥330 Mil as of Jun. 2026. GuruFocus rates SHSE:603334 with a GF Score™ of 44/100. The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Suzhou Fengbei Biotech Stock Co's Marketable Securities for the quarter that ended in Jun. 2026 was ¥330 Mil.

Suzhou Fengbei Biotech Stock Co's annual Marketable Securities stayed the same from Dec. 2023 (¥0 Mil) to Dec. 2024 (¥0 Mil) but then increased from Dec. 2024 (¥0 Mil) to Dec. 2025 (¥300 Mil).

Suzhou Fengbei Biotech Stock Co  (SHSE:603334) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Suzhou Fengbei Biotech Stock Co Marketable Securities Related Terms

Suzhou Fengbei Biotech Stock Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Suzhou Fengbei Biotech Stock Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Suzhou Fengbei Biotech Stock Co Marketable Securities Chart

Suzhou Fengbei Biotech Stock Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial 0.18 0.83 0.00 0.00 300.14

Suzhou Fengbei Biotech Stock Co Quarterly Data
Dec20 Dec21 Dec22 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.01 300.14 130.01 330.00
SHSE:603334
44GF Score
Suzhou Fengbei Biotech Stock Co Ltd SHSE:603334
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Suzhou Fengbei Biotech Stock Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ¥330 Mil mean?
Suzhou Fengbei Biotech Stock Co (SHSE:603334) has a Marketable Securities of ¥330 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Suzhou Fengbei Biotech Stock Co and its competitors.
Is Suzhou Fengbei Biotech Stock Co's Marketable Securities too high?
Suzhou Fengbei Biotech Stock Co's current Marketable Securities is ¥330 Mil. Overall, Suzhou Fengbei Biotech Stock Co has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Suzhou Fengbei Biotech Stock Co's Marketable Securities compare to WM and RSG?
Suzhou Fengbei Biotech Stock Co's Marketable Securities of ¥330 Mil can be compared against companies in the Waste Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Waste Management company?
A good Marketable Securities depends on the Waste Management industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Suzhou Fengbei Biotech Stock Co and its competitors. Suzhou Fengbei Biotech Stock Co's current Marketable Securities is ¥330 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzhou Fengbei Biotech Stock Co stock overvalued right now?
Suzhou Fengbei Biotech Stock Co (SHSE:603334) has a current Marketable Securities of ¥330 Mil. The current Marketable Securities is ¥330 Mil. Suzhou Fengbei Biotech Stock Co's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Suzhou Fengbei Biotech Stock Co (SHSE:603334), the current Marketable Securities is ¥330 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Suzhou Fengbei Biotech Stock Co Business Description

Address No. 1 Donghai Road, Yangtze River International Chemical Industrial Park, Jiangsu Province, Zhangjiagang, CHN, 215600
Suzhou Fengbei Biotech Stock Co Ltd is focused on the comprehensive utilization of waste oil and fat resources. The company is engaged in the research and development, production, and sales of industrial packaging materials, methyl oleate, and methylated soybean oil (excluding food products). It operates as an independent import and export agent for various commodities and technologies. The company's licensed projects include Fertilizer production, and General projects include Technical services, technical development, technical consultation, technical exchange, technology transfer, and technology promotion. It is into the research and development of bio-organic fertilizers, compound microbial fertilizers, and bio-pesticide technology.
44GF Score

Get the complete analysis for SHSE:603334

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥29.84
Price